Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Clinical trial NCT00473616 · TERMINATED

Trial details

NCT number: NCT00473616
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer Advanced Solid Malignancies

Start date: 2007-05-01
Primary completion: 2011-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.